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specificity for the a-fucosyn-
thases. Using b-L-fucosyl
azide as the donor, the
SsD242S mutant was able to
take 16 mono- and disaccha-
rides (so far tested) as accep-
tors for transglycosylation. All
the reactions proceeded in an
absolute stereo-specific con-
trol, leading to the formation
of a-linked fucoside deriva-
tives. The regio-selectivity
seemed to be dictated by
the structures of the acceptor
substrates. Thus, various
fucose-containing oligosac-
charides with a-1,2-, a-1,3-,
a-1,4- and/or a-1,6-fucosylated linkages
could be formed, depending on the
acceptors (Figure 2). Another interesting
feature of the fucosynthase-catalyzed
transglycosylation is the formation of
branched trisaccharides. Notably, non-
linear trisaccharides were observed in
the fucosynthase-catalyzed reactions,
implicating a novel acceptor recognition
mode for the new a-fucosynthases. It
should be pointed out that the ability of
the new a-fucosynthases to use the
stable b-fucosyl azide for transglycosyla-
tion is of particular importance for
practical synthesis. A recently reported
a-1,2-fucosynthase that was evolved to
use the labile b-fucosyl fluoride could
only give a very low (6%) yield, because
of the spontaneous hydrolysis of the
b-fucosyl fluoride during transglycosyla-
tion (Wada et al., 2008). The discovery of
the new a-fucosynthases thus opens
a new avenue to the practical synthesis
of biologically interesting fucose-contain-
ing oligosaccharides.
In summary, the new a-fucosynthases
described in this study constitute the first
a-fucosynthases derived from retaining
a-fucosidases. The remarkable acceptor
substrate promiscuity of these new
a-fucosynthases provides a unique
opportunity to discover various new
a-fucosynthases with tailored specificity
and/or enhanced activity by directed
evolution, as exemplified by a recent
report for evolving endo-glycoceramidase
(Hancock et al., 2009). Most importantly,
the new a-fucosynthases represent the
first a-glycosynthases that
can use b-glycosyl azide as
donor substrate for transgly-
cosylation. It is likely that other
glycosynthases can be
evolved to take correspond-
ing glycosyl azides for trans-
glycosylation, which clearly
indicates an exciting direction
to expand the repertoire of
glycosynthases.
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Figure 2. Synthesis of Fucose-Containing Oligosaccharides by
Fucosynthase-Catalyzed Transglycosylation
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In the recent issue of Molecular Cell, Neumann et al. dissect the effect of H3K56 acetylation on chromatin
structure using a novel method for generation of acetylated proteins. This is a valuable addition to the toolkit
for those interested in unraveling how posttranslational modifications regulate protein function.In the nucleus of eukaryotic cells, DNA is
tightly associated with proteins forming
a structure known as chromatin. These
protein/DNA associations allow high com-paction of the DNA, and e.g., at the same
time, ensure its accessibility for the tran-
scription and replication machinery. The
building blocks of chromatin are nucleo-Chemistry & Biology 16, October 30, 2009somes, which consist of a protein compo-
nent, built as an octamer of four core
histones (H2A, H2B, H3 and H4), around
which 147 base pairs of DNA areª2009 Elsevier Ltd All rights reserved 1027
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Previewswrapped. Histones are subject to several
covalent posttranslational modifications,
including methylation, phosphorylation,
andacetylation (Kouzarides, 2007).Modifi-
cations of histones, sometimes referred
to as a ‘‘histone code,’’ have been exten-
sively studied and can therefore serve as
an excellent model to address how post-
translational modifications govern protein
function.
Acetylation of lysine residues in histones
has been found tobe involved in the regula-
tion of all DNA dependent processes. In
addition to histones, many other proteins
are modified via lysine acetylation; a recent
mass spectrometry screen has identified
3600 acetylation sites on 1750 proteins
(Choudhary et al., 2009). There are two
main mechanisms proposed for the func-
tion of lysine acetylation: (i) it neutralizes
the basic charge of the lysine, which can
lead to changes in protein structure and/or
interactions; and (ii) it can serve as a signa-
ture to recruit ‘‘effectors’’ that specifically
recognize the acetylated protein, such as
chromatin-remodeling enzymes.
Proteins containing acetyl-lysine at
defined sites are important tools needed
tounravel the functionsof lysineacetylation.
Unfortunately, such proteins have been
very difficult to obtain thus far. One way to
produce them is by using lysine (K) acetyl-
transferases (KATs) to acetylate recombi-
nant proteins; however this approach has
several pitfalls. First, the KAT for the given
modification needs to be known; second,
it is difficult to control the degree of modifi-
cation as the enzymatic reaction is hardly
ever complete; and third, most KATs are
not specific for a single site.
Many researchers have chosen a dif-
ferent strategy that uses an acetyl-lysine
mimicbysubstitutionof themodified lysine
by a glutamine, often using simultaneously
a lysine-to-arginine substitution as amimic
of the unmodified state. While this method
is widespread due to its simplicity and
the possibility to apply both in vivo and
in vitro, the acetylation mimic is far from
perfect because of differences in the struc-
ture of glutamine and N3-acetyl-lysine (Fig-
ures 1A and 1B).
To overcome these limitations, native
chemical ligation has been applied to
produce acetylated proteins (He et al.,
2003). In this strategy, a peptide contain-
ing a modified amino acid is chemically
synthesized and then ligated to the
remainder of the protein of interest, which
is recombinantly produced containing an
engineered N-terminal cysteine residue.
This approach results in a homogenously
modified protein and has been proven
useful in multiple studies, such as the
one performed by Shogren-Knaak et al.
(2006) that demonstrated the role of acet-
ylation of histone H4K16 in chromatin
structure. However, chemical ligation has
some drawbacks as well: it is difficult to
introduce modifications located in the
central part of proteins, and it requires
advanced chemical skills.
Another breakthrough came with the
introduction of analogs ofmodified lysines.
Two groups have reported methods to
chemically generatemethyl-lysine analogs
based on the cysteine thiol group reactivity
(Simon et al., 2007; Bernardes et al., 2008).
While anacetyl-lysineanalogcould, inprin-
ciple, also be generated on the cysteine
platform, to our knowledge this has not
been reported yet. Recently, Guo et al.
(2008) have succeeded in creating an
acetyl-lysine analog starting with phenyl-
selenocysteine. The main advantage of
these strategies is that the analog can be
incorporated at any site in the protein, and
this approach has been already applied
successfully in several studies. However,
the replacement of the g-carbon of the
lysine with a sulfur (Figure 1C) can change
the properties of the side chain, because
the C-S bond is slightly longer than the
C-Cbond,hasaslightlysmallerbondangle
around that center, has two lone pairs
instead of two hydrogen substituents,
and reduces the pKa of the amine by 1.1
units.
Last year, Neumann et al. (2008) pub-
lished an innovative strategy to generate
acetylated proteins by genetically encod-
ing acetyl-lysine. In their inspiring work,
they demonstrated the site-specific incor-
poration of acetyl-lysine in recombinant
proteins produced in Escherichia coli by
an orthogonal N3-acetyllysyl-tRNA synthe-
tase/tRNACUA pair. This pair was derived
from Methanosarcina barkeri MS pyrroly-
syl-tRNA synthetase and its cognate
amber suppressor tRNA introduced into
E. coli, and subjected to several rounds of
selection for incorporation of acetyl-lysine
in response to the amber codon. This
technology represents a straight-forward
method to generate high amounts of native
Figure 1. Mimicking Lysine Acetylation
(A) Structure of lysine and N3-acetyl-lysine.
(B) Structure of arginine and glutamine, amino acids used to mimic the unmodified and acetylated lysine,
respectively.
(C) Structure of acetyl-lysine analog (Guo et al., 2008).
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only limitation at the current state might be
the difficulty to obtain proteins acetylated
at multiple sites since the stop codon
suppression by tRNACUA can be incom-
plete, resulting in truncated proteins.
Recently, the same group succeeded in
producing lysinemethylatedproteinsusing
an analogous system, thus also providing
this new tool now to the methylation
community (Nguyen et al., 2009).
In the current issue of Molecular Cell,
Neumann and colleagues (2009) go an
important step further and report a
proof-of-principle application of their new
method to investigate the effects of
histone H3 acetylation on K56 (H3K56ac)
on chromatin structure and compaction.
H3K56ac is a modification conserved
from yeast to humans, localized in the
globular core of H3. It has been shown
that H3K56ac is involved in DNA repair
and replication, chromatin assembly,
and regulation of transcription (reviewed
in Downs (2008)). Because H3K56 is in
close contact to the DNA at the entry-
exit point of the nucleosome, the con-
cept that its acetylation affects chro-
matin compaction has been previously
made in the literature. Now, using their
elegant approach, Neumann et al. (2009)
reconstituted ‘‘designer’’ octamers,
nucleosomes, and nucleosomal arrays
specifically acetylated at H3K56. They
employed then single molecule FRET
(fluorescence resonance energy transfer),
sedimentation velocity analysis, and
mononucleosome repositioning assays
to show that, surprisingly, H3K56ac hasno direct effect on the compaction of
chromatin. However, they found that it
increases DNA breathing at the entry-exit
point of the nucleosome, slightly changing
the nucleosome structure. Interestingly,
while H3K56ac did not enhance the
binding of nucleosomes to the chromatin
remodellers SWI/SNF, RSC or Brdf1, it
did have a slight positive effect on nucleo-
some redistribution byRSCandSWI/SNF.
Taken together, this work demonstrates,
using histones as a model, that the new
method has the potential to revise prevail-
ing dogmas regarding the effects of lysine
acetylation.
The novel technology will have a vast
variety of applications. It will undoubtedly
advance the histone acetylation field by
allowing in vitro assays such as chromatin
compaction, remodeling, and binding
partner studies. However, we should not
forget that there are 1750 or more acety-
lated nonhistone proteins in the cell
(Choudhary et al., 2009), which likewise
await functional characterization.
Orthogonal aminoacyl-tRNA synthe-
tase/tRNA pairs have also been devel-
oped in Saccharomyces cerevisiae (Chin
et al., 2003) and mammals (Sakamoto
et al., 2002), which, in principle, could
allow to genetically encode lysine modifi-
cations in eukaryotes in vivo. Thus, in
the future, the method developed by
Chin and colleagues can provide us with
straightforward synthetic biology tools to
unravel the molecular mechanisms and
functions of a wide range of protein post-
translational modifications in vitro and
in vivo.Chemistry & Biology 16, October 30, 2009REFERENCES
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